Forma Therapeutics, a Novo Nordisk company
Forma Therapeutics, a Novo Nordisk company, is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our work has generated a broad, proprietary portfolio of programs with the potential to provide profound patient benefit, including our sickle cell disease program, etavopivat (FT-4202). Click the link above to visit our corporate website or visit us in person at booth #143.